Cargando…

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

OBJECTIVE: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes. METHODS: Men with BRCA1/...

Descripción completa

Detalles Bibliográficos
Autores principales: Moynihan, C., Bancroft, E.K., Mitra, A., Ardern‐Jones, A., Castro, E., Page, E.C., Eeles, R.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698714/
https://www.ncbi.nlm.nih.gov/pubmed/28812325
http://dx.doi.org/10.1002/pon.4530
_version_ 1783280811209916416
author Moynihan, C.
Bancroft, E.K.
Mitra, A.
Ardern‐Jones, A.
Castro, E.
Page, E.C.
Eeles, R.A.
author_facet Moynihan, C.
Bancroft, E.K.
Mitra, A.
Ardern‐Jones, A.
Castro, E.
Page, E.C.
Eeles, R.A.
author_sort Moynihan, C.
collection PubMed
description OBJECTIVE: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes. METHODS: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data were analysed using a framework approach. “Masculinity theory” was used to report the impact of having both a BRCA1/2 mutation and PCa. RESULTS: Eleven of 15 eligible men were interviewed. The umbrella concept of “Ambiguity in a Masculine World” was evident. Men's responses often matched those of women in a genetic context. Men's BRCA experience was described, as “on the back burner” but “a bonus” enabling familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men revealed stereotypical “ideal” masculine responses such as stoicism and control while creating new “masculinities” when faced with the vicissitudes of having 2 gendered conditions. CONCLUSION: Health workers are urged to take a reflexive approach, void of masculine ideals, a belief in which obfuscates men's experience. Research is required regarding men's support needs in the name of equality of care.
format Online
Article
Text
id pubmed-5698714
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56987142017-11-30 Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer Moynihan, C. Bancroft, E.K. Mitra, A. Ardern‐Jones, A. Castro, E. Page, E.C. Eeles, R.A. Psychooncology Papers OBJECTIVE: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes. METHODS: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data were analysed using a framework approach. “Masculinity theory” was used to report the impact of having both a BRCA1/2 mutation and PCa. RESULTS: Eleven of 15 eligible men were interviewed. The umbrella concept of “Ambiguity in a Masculine World” was evident. Men's responses often matched those of women in a genetic context. Men's BRCA experience was described, as “on the back burner” but “a bonus” enabling familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men revealed stereotypical “ideal” masculine responses such as stoicism and control while creating new “masculinities” when faced with the vicissitudes of having 2 gendered conditions. CONCLUSION: Health workers are urged to take a reflexive approach, void of masculine ideals, a belief in which obfuscates men's experience. Research is required regarding men's support needs in the name of equality of care. John Wiley and Sons Inc. 2017-09-18 2017-11 /pmc/articles/PMC5698714/ /pubmed/28812325 http://dx.doi.org/10.1002/pon.4530 Text en © 2017 The Authors. Psycho‐Oncology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Papers
Moynihan, C.
Bancroft, E.K.
Mitra, A.
Ardern‐Jones, A.
Castro, E.
Page, E.C.
Eeles, R.A.
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title_full Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title_fullStr Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title_full_unstemmed Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title_short Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
title_sort ambiguity in a masculine world: being a brca1/2 mutation carrier and a man with prostate cancer
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698714/
https://www.ncbi.nlm.nih.gov/pubmed/28812325
http://dx.doi.org/10.1002/pon.4530
work_keys_str_mv AT moynihanc ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT bancroftek ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT mitraa ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT ardernjonesa ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT castroe ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT pageec ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer
AT eelesra ambiguityinamasculineworldbeingabrca12mutationcarrierandamanwithprostatecancer